WO2014098764A1 - Topical treatment delivery system - Google Patents

Topical treatment delivery system Download PDF

Info

Publication number
WO2014098764A1
WO2014098764A1 PCT/SG2012/000485 SG2012000485W WO2014098764A1 WO 2014098764 A1 WO2014098764 A1 WO 2014098764A1 SG 2012000485 W SG2012000485 W SG 2012000485W WO 2014098764 A1 WO2014098764 A1 WO 2014098764A1
Authority
WO
WIPO (PCT)
Prior art keywords
solution
membrane
poly
tcm
nano
Prior art date
Application number
PCT/SG2012/000485
Other languages
French (fr)
Inventor
Pak Ho Henry Leung
Wai To Fung
Original Assignee
Conifer Living Formulas Pte Ltd
Clearbridge Nanomedics Pte Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Conifer Living Formulas Pte Ltd, Clearbridge Nanomedics Pte Ltd filed Critical Conifer Living Formulas Pte Ltd
Priority to PCT/SG2012/000485 priority Critical patent/WO2014098764A1/en
Publication of WO2014098764A1 publication Critical patent/WO2014098764A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0212Face masks
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations

Definitions

  • Topical treatment delivery system
  • the present invention relates to a topical treatment delivery system.
  • TCM Traditional Chinese Medicine
  • the invention proposes a soluble nano-fibre membrane incorporating a TCM extract.
  • the membrane may slowly dissolve, which may thereby topically deliver the treatment in a controlled and user friendly manner.
  • the membrane may be in the shape of a facemask to apply the treatment to the face of a user.
  • the treatment may include skin clearing (anti acne), skin whitening, skin rejuvenation and firming, and/or skin lightening (anti-pigmentation).
  • the membrane may be fabricated using needless electro-spinning, which may ensure the over 90% of the active compounds remain viable throughout fabrication, and may provide a lower cost and higher throughput production process. This process may allow for both polar and non-polar chemical compounds from a TCM formulation to be viably incorporated into the membrane and to be controllably topically delivered.
  • Embodiments may be implemented according to any of claims 2-3 or 5 to 14. BRIEF DESCRIPTION OF THE DRAWINGS
  • Figure 1 is a plan view of the facemask according to an example embodiment.
  • Figure 2 is a flow diagram of a method of fabrication according to an example embodiment.
  • Figure 3 is a recipe for the TCM Skin Clearing (anti-acne) Formulation.
  • Figure 4 is a recipe for the TCM Skin Whitening Formulation.
  • Figure 5 is a recipe for the TCM Skin Rejuvenation Firming Formulation.
  • Figure 6 is a recipe for the TCM Skin Lightening (Anti-Pigmentation) Formulation.
  • Figure 7 is a table of the High-performance liquid chromatography (HPLC) analysis before and after electro-spinning.
  • Figure 8 is a graph of the HPLC analysis of a solution including the TCM formulation for Whitening including with PEO polymer before electro-spinning.
  • Figure 9 is a graph of the HPLC analysis of an electro-spun membrane encapsulating the Whitening TCM formulation.
  • Figure 10 is a table comparing the organic and non-organic extraction efficiency for 90% water 0% ethanol buffer, and for the 2 stage extraction process with 9:1 mix ratio.
  • Figure 11 is graphs of the HPLC analysis of the solution after extraction by (a) water, (b) ethanol, (c) 90% water 10% ethanol buffer, and (d) 2 stage extraction process with 9:1 mix ratio.
  • a topical treatment delivery system 100 is shown in Figure 1 according to the example embodiment.
  • a face mask 102 includes apertures for the user's eyes 104, nose 106 and mouth 108, and slit's 110 to accommodate the typical facial contours around the periphery.
  • the mask 102 is fabricated from a membrane which encapsulates a TCM formulation.
  • a membrane which encapsulates a TCM formulation.
  • the membrane is activated by the face being completed wetted, either by applying water or a designed activation gel.
  • the membrane then dissolves and the TCM formulation precipitates out as a uniformly distributed solid residue on the user's face.
  • the mask 102 may be left on for 15min or until the membrane has completed dissolved.
  • the membrane may be fabricated according to the method 200 shown in Figure 2 according to the example embodiment.
  • a TCM formulation is selected and prepared 202 according to any of the recipes show in Figures 1 to 4.
  • the formulation may initially be a dry fine grounded powder mixture.
  • a solution including a polymer is prepared 204.
  • the solution is electro-spun 206 into a nano-fibre membrane.
  • the membrane may be a single fibre layer or it may have multiple layers. The different layers may have different TCM extracts for a dual or combination effects mask.
  • the active compounds from the TCM formulation powder are dissolved using one or more processes, depending on the type of compounds to be extracted.
  • polar, non polar, and essential/crude oil extraction may all be extracted using separate techniques. Some of the extractions may be combined for use in electro-spinning a single layer, or may be used in fabricating separate nano-fibre layers in a multi layer membrane.
  • Ethanol is used to extract non-polar small molecules.
  • the mixture may be left to stand for several hours or may be agitated to increase the rate of extraction.
  • the mixture may be sonicated for about 30-60 minutes, and then Autoclaved at 90 to 130°C eg: 121°C, for 10 to 90 minutes, eg: 20 minutes. Then the mixture is centrifuged at 6,000 rpm for 30 minutes. The solution is filtered using a cellulose filter or membrane filter with pore size around 0.45um.
  • the remaining solids are removed from the filter and are mixed into a buffer or aqueous solution at about 0.05-0.5 g/ml at a temperature of between 25°C to 60°C.
  • the buffer or aqueous solution aids to extract polar small molecules in the formulation.
  • the mixture may be left to stand for several hours or may be agitated to increase the rate of extraction.
  • the mixture may be sonicated for about 30-60 minutes, and then Autoclaved at 90 to 130°C eg: 121 °C, for 10 to 90 minutes, eg: 20 minutes. Then the mixture is centrifuged at 16,000 rpm for 30 minutes.
  • the solution is filtered using cellulose filter or membrane filter with pore size around 0.45um.
  • TCM extract includes essential or crude oil, this may need to be separately extracted
  • the TGM formulation powders are mixed into a buffer solution or aqueous or organic solvent at about 0.05-0.5 g/ml at a temperature of between 25°C to 60°C.
  • the buffer solution or aqueous or organic solvent aids to extract total molecules in the formulation.
  • the mixture may be left to stand for several hours or may be agitated to increase the rate of extraction.
  • the mixture may be sonicated for about 30-60 minutes, and then Autoclaved at 90 to 130°C eg: 121 °C, for 10 to 180 minutes, eg: 60 minutes. Then the mixture is centrifuged at 16,000 rpm for 30 minutes.
  • the solution is filtered using, cellulose filter or membrane filter with pore size around 0.45um.
  • the solution will evaporate at 60-100°C, example 80°C, under reduced pressure (under vacuum) for 1-6hr, example 2hr.
  • the remaining liquid represents the essential/crude oil extraction from the formulation.
  • Essential/crude oil extraction may be used for direct polymer mixing without further combination. For example it may be provided as a separate layer in a multi layer nano-fibre membrane.
  • a polymer (Polyethylene Oxide (PEO), MV 500-700k) is mixed with the final TCM extracted solution at 25°C to 70°C for 1 hour. After mixing, the solution is left to cool for 30 minutes to allow small molecule-polymerization.
  • PEO Polyethylene Oxide
  • the resulting polymer solution is used for membrane fabrication 206 via electro-spinning. Electro-spinning
  • the solution is provided for needless electro-spinning at 30kV; solution flow rate at 0.8ml/hr and collector rotator speed at 100 rpm.
  • a 80%nylon/20% polyester honeycombed/netting structure based substrate may be the backing layer. This may be done at room temperature and pressure with collection distance at 8 to 12 cm.
  • the membrane thickness is between 15 urn to 50 urn.
  • the needle spec is 0.5 to 1 inch, and 18G to 25G size.
  • the membrane will place UV overnight at room temperature and under vacuum before physical cutting, example face-mask design or any other sizes. Correct cutting membrane will be sealed in packaging under vacuum.
  • the non polar solvent may be 100% ethanol.
  • it may also be methanol, dichloromethane, acetone nitrate etc. .
  • the polar solvent may be distilled water or a salt solution, which reduces undesirable compounds, especially polar compounds.
  • a salt solution for example, sodium phosphate, sodium acetate, and sodium bicarbonate, or alternatively a mild acid such as acetic acid.
  • Suitable concentrations of the buffer solution using these various compounds are in the range of about 0.05 -0. 5M, most suitably about a 0.1 M solution of sodium phosphate, sodium acetate or sodium bicarbonate, or a 0.5% acetic acid solution.
  • the polymer may be any soluble and insoluble polymers, for example Poly(acrylamide/acrylic acid); Poly(Diallyl Dimethyl Ammonium Chloride); Poly(2- vinylpyridine N-oxide); Poly(ethylene glycol); Poly(ethylene oxide) ; Polyvinylpyrrolidone); Polyvinyl alcohol); Polypropylene.
  • Suitable molecular size of soluble and insoluble polymers are range of about 1000 - 100,000 MW.
  • the extraction process might be expected to deliver 120 mg of soluble and insoluble small molecules for every per gram of dry powder TCM formulation. In turn more than 97% of those soluble and insoluble small molecule might be expected to be viably retained in polymer mixture and/or the polymer membrane after electro-spinning.
  • Figures 10 and 11 show that 90% water-10% Ethanol pre-mixed extract buffer allows 94% of total water soluble compounds to be extracted with 6% of total organic compounds to be extracted. Using the two step 100% ethanol followed by water extraction mentioned above (with a 9:1 mixing ratio) allows 90% of total water soluble compounds to be extracted with more than 10% of total organic compounds to be extracted. This represents a two fold increase in organic compounds present compared with the standard prior art extraction method.
  • the small molecule level of each sample was assay by standard laboratory small molecule assay, for example a Lowry Potein Assay.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A topical treatment delivery system comprising: a backing layer configured to accommodate the facial contours of a user, a soluble nano-fibre membrane affixed to the backing layer, and a TCM extract encapsulated in the membrane configured for topical delivery to the face. Also a method of fabricating a membrane for topical treatment delivery to the face of a user, and a face mask.

Description

Topical treatment delivery system
FIELD
The present invention relates to a topical treatment delivery system. BACKGROUND
It is know to provide various types of dressing for wounds. For example in International Patent publication number WO 2006/036130 a composite dressing is provided for wound care. However the composite nano-fibre is fabricated using needle electro spinning, which has a high energy requirement and is quite slow.
Increasingly alternative or herbal remedies are becoming popular. For certain types of herbal remedy it may be desirable to apply the formula topically. However often such remedies are difficult to apply, especially topically, and are not user friendly. Moreover the composite in WO 2006/036130 is not well suited to delivering such remedies.
Further improvements in treatment delivery devices include International Patent publication number WO 2009/045342, which discloses a solution spinning method for fabricating a nano-fibre including essential oils. Korean Patent number KR20110077792 describes electro-spinning a hydrophilic polyurethane nano-fibre or polyurethane web. Cosmetic treatment is impregnated within the web. US2011229551 is a biodegradable sustained release drug delivery nano-fibre web. The web is then implanted into the vitreous cavity within the eye.
However for remedies such as Traditional Chinese Medicine (TCM), it maybe important for the active compounds in the powered extracts to remain viable throughput the fabrication process. It may also be important to ensure that the active compounds are delivered topically in a controlled and user friend manner.
SUMMARY
It may therefore be desirable to provide a topical treatment delivery system which goes some way to overcoming one or more of the problems mentioned above, or which will at least give the public a useful choice.
In general terms the invention proposes a soluble nano-fibre membrane incorporating a TCM extract. Upon application to a user's skin the membrane may slowly dissolve, which may thereby topically deliver the treatment in a controlled and user friendly manner. The membrane may be in the shape of a facemask to apply the treatment to the face of a user. The treatment may include skin clearing (anti acne), skin whitening, skin rejuvenation and firming, and/or skin lightening (anti-pigmentation). The membrane may be fabricated using needless electro-spinning, which may ensure the over 90% of the active compounds remain viable throughout fabrication, and may provide a lower cost and higher throughput production process. This process may allow for both polar and non-polar chemical compounds from a TCM formulation to be viably incorporated into the membrane and to be controllably topically delivered.
In a first specific expression of the invention there is provided a topical treatment delivery system according to claim 1.
In a second specific expression of the invention there is provided a method of fabricating a membrane according to claim 4.
Embodiments may be implemented according to any of claims 2-3 or 5 to 14. BRIEF DESCRIPTION OF THE DRAWINGS
One or more example embodiments of the invention will now be described, with reference to the following figures, in which:
Figure 1 is a plan view of the facemask according to an example embodiment.
Figure 2 is a flow diagram of a method of fabrication according to an example embodiment.
Figure 3 is a recipe for the TCM Skin Clearing (anti-acne) Formulation.
Figure 4 is a recipe for the TCM Skin Whitening Formulation.
Figure 5 is a recipe for the TCM Skin Rejuvenation Firming Formulation.
Figure 6 is a recipe for the TCM Skin Lightening (Anti-Pigmentation) Formulation.
Figure 7 is a table of the High-performance liquid chromatography (HPLC) analysis before and after electro-spinning.
Figure 8 is a graph of the HPLC analysis of a solution including the TCM formulation for Whitening including with PEO polymer before electro-spinning.
Figure 9 is a graph of the HPLC analysis of an electro-spun membrane encapsulating the Whitening TCM formulation.
Figure 10 is a table comparing the organic and non-organic extraction efficiency for 90% water 0% ethanol buffer, and for the 2 stage extraction process with 9:1 mix ratio. Figure 11 is graphs of the HPLC analysis of the solution after extraction by (a) water, (b) ethanol, (c) 90% water 10% ethanol buffer, and (d) 2 stage extraction process with 9:1 mix ratio.
DESCRIPTION
A topical treatment delivery system 100 is shown in Figure 1 according to the example embodiment. A face mask 102 includes apertures for the user's eyes 104, nose 106 and mouth 108, and slit's 110 to accommodate the typical facial contours around the periphery.
The mask 102 is fabricated from a membrane which encapsulates a TCM formulation. When the mask 102 is applied to the user's face, it will loosely follow the contours of the face while the face is dry due to the slits 110 and apertures 104,106,108. The membrane is activated by the face being completed wetted, either by applying water or a designed activation gel. The membrane then dissolves and the TCM formulation precipitates out as a uniformly distributed solid residue on the user's face. The mask 102 may be left on for 15min or until the membrane has completed dissolved.
The membrane may be fabricated according to the method 200 shown in Figure 2 according to the example embodiment. A TCM formulation is selected and prepared 202 according to any of the recipes show in Figures 1 to 4. The formulation may initially be a dry fine grounded powder mixture. Subsequently a solution including a polymer is prepared 204. The solution is electro-spun 206 into a nano-fibre membrane. The membrane may be a single fibre layer or it may have multiple layers. The different layers may have different TCM extracts for a dual or combination effects mask.
Lastly the membrane is cut and packaged 208. The method 200 is explained in more detail below.
Firstly the active compounds from the TCM formulation powder are dissolved using one or more processes, depending on the type of compounds to be extracted. For example polar, non polar, and essential/crude oil extraction may all be extracted using separate techniques. Some of the extractions may be combined for use in electro-spinning a single layer, or may be used in fabricating separate nano-fibre layers in a multi layer membrane.
Non-polar molecule extraction
100% Ethanol is used to extract non-polar small molecules. The mixture may be left to stand for several hours or may be agitated to increase the rate of extraction. For example, the mixture may be sonicated for about 30-60 minutes, and then Autoclaved at 90 to 130°C eg: 121°C, for 10 to 90 minutes, eg: 20 minutes. Then the mixture is centrifuged at 6,000 rpm for 30 minutes. The solution is filtered using a cellulose filter or membrane filter with pore size around 0.45um.
Polar molecule extraction
The remaining solids are removed from the filter and are mixed into a buffer or aqueous solution at about 0.05-0.5 g/ml at a temperature of between 25°C to 60°C. The buffer or aqueous solution aids to extract polar small molecules in the formulation. The mixture may be left to stand for several hours or may be agitated to increase the rate of extraction. For example, the mixture may be sonicated for about 30-60 minutes, and then Autoclaved at 90 to 130°C eg: 121 °C, for 10 to 90 minutes, eg: 20 minutes. Then the mixture is centrifuged at 16,000 rpm for 30 minutes. The solution is filtered using cellulose filter or membrane filter with pore size around 0.45um.
Extract combining
10-30% of the Ethanol extract solution is mixed with 90-70% of the buffer or aqueous extract solution to result in the final TCM extracted solution. Essential/crude oil extraction
If the TCM extract includes essential or crude oil, this may need to be separately extracted The TGM formulation powders are mixed into a buffer solution or aqueous or organic solvent at about 0.05-0.5 g/ml at a temperature of between 25°C to 60°C. The buffer solution or aqueous or organic solvent aids to extract total molecules in the formulation. The mixture may be left to stand for several hours or may be agitated to increase the rate of extraction. For example, the mixture may be sonicated for about 30-60 minutes, and then Autoclaved at 90 to 130°C eg: 121 °C, for 10 to 180 minutes, eg: 60 minutes. Then the mixture is centrifuged at 16,000 rpm for 30 minutes. The solution is filtered using, cellulose filter or membrane filter with pore size around 0.45um. The solution will evaporate at 60-100°C, example 80°C, under reduced pressure (under vacuum) for 1-6hr, example 2hr. The remaining liquid represents the essential/crude oil extraction from the formulation. Essential/crude oil extraction may be used for direct polymer mixing without further combination. For example it may be provided as a separate layer in a multi layer nano-fibre membrane.
Then the solution is combined 204 with the polymer. Polymer mixing
A polymer (Polyethylene Oxide (PEO), MV 500-700k) is mixed with the final TCM extracted solution at 25°C to 70°C for 1 hour. After mixing, the solution is left to cool for 30 minutes to allow small molecule-polymerization.
The resulting polymer solution is used for membrane fabrication 206 via electro-spinning. Electro-spinning
The solution is provided for needless electro-spinning at 30kV; solution flow rate at 0.8ml/hr and collector rotator speed at 100 rpm. A 80%nylon/20% polyester honeycombed/netting structure based substrate may be the backing layer. This may be done at room temperature and pressure with collection distance at 8 to 12 cm. The membrane thickness is between 15 urn to 50 urn. The needle spec is 0.5 to 1 inch, and 18G to 25G size.
Lastly the membrane is cut and packaged 208. Cutting and Packaging
The membrane will place UV overnight at room temperature and under vacuum before physical cutting, example face-mask design or any other sizes. Correct cutting membrane will be sealed in packaging under vacuum.
The non polar solvent may be 100% ethanol. For other application it may also be methanol, dichloromethane, acetone nitrate etc. .
The polar solvent may be distilled water or a salt solution, which reduces undesirable compounds, especially polar compounds. For example, sodium phosphate, sodium acetate, and sodium bicarbonate, or alternatively a mild acid such as acetic acid. Suitable concentrations of the buffer solution using these various compounds are in the range of about 0.05 -0. 5M, most suitably about a 0.1 M solution of sodium phosphate, sodium acetate or sodium bicarbonate, or a 0.5% acetic acid solution.
The polymer may be any soluble and insoluble polymers, for example Poly(acrylamide/acrylic acid); Poly(Diallyl Dimethyl Ammonium Chloride); Poly(2- vinylpyridine N-oxide); Poly(ethylene glycol); Poly(ethylene oxide) ; Polyvinylpyrrolidone); Polyvinyl alcohol); Polypropylene. Suitable molecular size of soluble and insoluble polymers are range of about 1000 - 100,000 MW. The extraction process might be expected to deliver 120 mg of soluble and insoluble small molecules for every per gram of dry powder TCM formulation. In turn more than 97% of those soluble and insoluble small molecule might be expected to be viably retained in polymer mixture and/or the polymer membrane after electro-spinning. Figures 7 to 9 and show that the electrospinning methodology encapsulates over 75% of the starting compounds.
Figures 10 and 11 show that 90% water-10% Ethanol pre-mixed extract buffer allows 94% of total water soluble compounds to be extracted with 6% of total organic compounds to be extracted. Using the two step 100% ethanol followed by water extraction mentioned above (with a 9:1 mixing ratio) allows 90% of total water soluble compounds to be extracted with more than 10% of total organic compounds to be extracted. This represents a two fold increase in organic compounds present compared with the standard prior art extraction method.
The small molecule level of each sample was assay by standard laboratory small molecule assay, for example a Lowry Potein Assay.
While example embodiments of the invention have been described in detail, many variations are possible within the scope of the invention as claimed as will be clear to a skilled reader.

Claims

CLAIMS:
1. A topical treatment delivery system comprising:
a backing layer configured to accommodate the facial contours of a user, a soluble nano-fibre membrane affixed to and/or supported by the backing layer, and
a TCM extract encapsulated in the membrane configured for topical delivery to the face.
2. The system in claim 1 wherein the membrane thickness is between 15 um to 50 um.
3. The system in claim 1 wherein the TCM extract is configured for treatment of skin clearing (anti acne), skin whitening, skin rejuvenation and firming, and/or skin lightening (anti-pigmentation).
4. A method of fabricating a membrane for topical treatment delivery to the face of a user, comprising:
dissolving a TCM extract in solution,
mixing the solution with one or more polymers to allow soluble and insoluble small molecule polymerisation, and
electro-spinning the polymerised solution into a nano-fibre membrane
5. The method in claim 4 further comprising electro-spinning a different polymerised solution, encapsulated a TCM extract configured for treatment of a different condition, into a second nano-fibre membrane on the first second nano-fibre membrane
6. The method in claim 4 or 5 wherein the dissolving step comprises dissolving the TCM extract in a non-polar solvent.
7. The method in claim 6 wherein the dissolving further comprises independently dissolving the TCM extract in a polar solvent.
8. The method in claim 7 wherein the dissolving further comprises
sonicating the solution for 30-60 minutes,
autoclaving the sonicated at 90 to 130°C, for 10 to 90 minutes,
centrifuging the autoclaved solution at 16,000 rpm for 30 minutes, and filtering the centrifuged solution.
9. The method in claims 7 or 8 wherein the polar solution is combined with the non- polar solution using a ratio of between 9:1 and 7:3.
10. The method in any one of claims 4 to 9 wherein the mixing comprises adding Poly(acrylamide/acrylic acid); Poly(Diallyl Dimethyl Ammonium Chloride); Poly(2- vinylpyridine N-oxide); Poly(ethylene glycol); Poly(ethylene oxide) ; Poly(N- vinylpyrrolidone); and/or Poly( vinyl alcohol) to the solution
11. The method in claim 10 wherein the mixing occurs at between 25°C to 70bC for 1 hour.
12. The method in any one of claims 4 to 11 wherein the electro-spinning comprises applying a voltage of 30kV; a solution flow rate of 0.8ml/hr, collector rotator speed at 100 rpm, a collection distance of 8 to 12 cm, a needle spec is 0.5 to 1 inch, and/or 18G to 25G size.
13. The method in any one of claims 4 to 12 wherein the soluble nano-fibre membrane is multi layer.
14. The method in claim 13 wherein a first layer of the multi layer membrane encapsulates an essential oil or crude oil extraction.
15. A face mask fabricated according to the method of any one of claims 4 to 14.
PCT/SG2012/000485 2012-12-21 2012-12-21 Topical treatment delivery system WO2014098764A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/SG2012/000485 WO2014098764A1 (en) 2012-12-21 2012-12-21 Topical treatment delivery system

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/SG2012/000485 WO2014098764A1 (en) 2012-12-21 2012-12-21 Topical treatment delivery system

Publications (1)

Publication Number Publication Date
WO2014098764A1 true WO2014098764A1 (en) 2014-06-26

Family

ID=50978896

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/SG2012/000485 WO2014098764A1 (en) 2012-12-21 2012-12-21 Topical treatment delivery system

Country Status (1)

Country Link
WO (1) WO2014098764A1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108498396A (en) * 2018-04-24 2018-09-07 上海益好纳米科技有限公司 A series of disposable hypersorption type nanofiber functional masks and preparation method thereof
WO2020199739A1 (en) * 2019-03-31 2020-10-08 山西慧虎健康科技有限公司 Big image data-based system and method for smart testing and conditioning of traditional chinese medicine constitutions
CN107007477B (en) * 2016-01-27 2021-05-04 李和伟 Preparation process of modified membrane cloth by multilayer modification method and product thereof
WO2023052565A1 (en) 2021-09-29 2023-04-06 Uea Enterprises Limited Dry creams and topical delivery systems

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005529960A (en) * 2002-06-21 2005-10-06 ザ ユニバーシティー オブ ニューキャッスル リサーチ アソシエイツ (ティーユーエヌアールエイ)リミテッド Probiotics, Propionibacterium ienseni 702
JP2008514341A (en) * 2004-09-29 2008-05-08 ナショナル ユニバーシティ オブ シンガポール COMPOSITE, METHOD FOR PRODUCING COMPOSITE, AND METHOD OF USING THE SAME
WO2009031620A1 (en) * 2007-09-05 2009-03-12 Taiyokagaku Co., Ltd. Water-soluble electrospun sheet
WO2012002391A1 (en) * 2010-06-29 2012-01-05 花王株式会社 Nanofibre laminate sheet
JP2012012714A (en) * 2010-06-29 2012-01-19 Kao Corp Nanofiber

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005529960A (en) * 2002-06-21 2005-10-06 ザ ユニバーシティー オブ ニューキャッスル リサーチ アソシエイツ (ティーユーエヌアールエイ)リミテッド Probiotics, Propionibacterium ienseni 702
JP2008514341A (en) * 2004-09-29 2008-05-08 ナショナル ユニバーシティ オブ シンガポール COMPOSITE, METHOD FOR PRODUCING COMPOSITE, AND METHOD OF USING THE SAME
WO2009031620A1 (en) * 2007-09-05 2009-03-12 Taiyokagaku Co., Ltd. Water-soluble electrospun sheet
WO2012002391A1 (en) * 2010-06-29 2012-01-05 花王株式会社 Nanofibre laminate sheet
JP2012012714A (en) * 2010-06-29 2012-01-19 Kao Corp Nanofiber

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107007477B (en) * 2016-01-27 2021-05-04 李和伟 Preparation process of modified membrane cloth by multilayer modification method and product thereof
CN108498396A (en) * 2018-04-24 2018-09-07 上海益好纳米科技有限公司 A series of disposable hypersorption type nanofiber functional masks and preparation method thereof
WO2020199739A1 (en) * 2019-03-31 2020-10-08 山西慧虎健康科技有限公司 Big image data-based system and method for smart testing and conditioning of traditional chinese medicine constitutions
WO2023052565A1 (en) 2021-09-29 2023-04-06 Uea Enterprises Limited Dry creams and topical delivery systems

Similar Documents

Publication Publication Date Title
WO2014098764A1 (en) Topical treatment delivery system
EP3060195B1 (en) Cosmetic composition based on hyaluronic acid, method of preparation and use thereof
US20230020948A1 (en) Nanofibrous mat containing ceramic particles with releasable dopant
US20200009767A1 (en) Method and Device for Manufacturing Dissolving Microneedle
CN106794275A (en) For the system of release bioactive agent immediately
KR102038751B1 (en) Microneddle array with complex formulation and method for manufacturing the same
Costa-Fernandez et al. Nanostructured lipid carriers containing chitosan or sodium alginate for co-encapsulation of antioxidants and an antimicrobial agent for potential application in wound healing
KR20020079150A (en) Percutaneous Controlled Releasing Material Using Nano-sized Polymeric Particles and External Application Agent Containing the Same
CA2386810A1 (en) Electrospun skin masks and uses thereof
KR20140055205A (en) Thickened eye drop composition comprising polydeoxyribonucleotide and method thereof
EP3380081B1 (en) Method for preparing a stable controlled-release propolis colloidal dispersion system for various uses
CN108210346B (en) Composite wall material microcapsule loaded with salicylic acid and preparation method thereof
CN113648289B (en) Arginine deiminase lipid nanoparticle wrapped by lung cancer cell membrane and preparation method thereof
JP2017025431A (en) Collagen containing fiber structure
KR100757043B1 (en) Cationic polymer nanocapsules for the enhancement of skin penetration, and the cosmetic composition containing the same
CN1307253C (en) Chitosan water-retaining gel adhesive substrate materials and method for preparing same
Aljabali et al. Nanocelluloses as a novel vehicle for controlled drug delivery
CN111683650B (en) Cationized vesicle and composition thereof
CN108619553B (en) Preparation method and application of propolis-nano silver dressing
KR20170000750A (en) Soluble microneedle patch for delivery of diosmetin
WO2010023689A2 (en) Microparticles
KR20200045125A (en) Mask sheet and prepartion method thereof
KR20050087567A (en) Self-assembled polymeric nanoparticles containing ginsenosides and cosmetic compositions containing the nanoparticles
CN113018203A (en) Aqueous retinol dispersion, method for preparing same and use thereof
CN111001028A (en) Methylene blue antioxidant repair polymer nanofiber membrane and preparation method thereof

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12890585

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 12890585

Country of ref document: EP

Kind code of ref document: A1